TGTX
TG THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$53.30
−1.24%Forward multiples
Based on analyst estimates
- P/E forward
- 23.30x
- P/E 2026E
- 53.38x
- P/E 2027E
- 18.56x
- P/E 2028E
- 14.43x
- P/S forward
- 6.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.50x
- PEG TTM
- —
- Price / book
- 13.51x
- Price / sales
- 10.20x
- Price / cash flow
- 456.40x
Enterprise value
- Enterprise value
- $8.4B
- EV / sales
- 10.46x
- EV / EBITDA
- 62.27x
- EV / EBIT
- 61.33x
- Market cap
- $8.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026